Medline Convenience Kits Recall Involves Swan-Ganz Catheters
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries is recalling 9,272 convenience kits containing Swan-Ganz catheters due to potential leaks and breakage that may lead to infection or blood loss.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Medline Industries, LP is recalling convenience kits that contain Swan-Ganz catheters recalled by Becton Dickinson (BD). BD has received complaints of leaks/breakage involving failures of the (blue) proximal injectate lumen hub on these catheters. This has led to instances of leakage, lumen damage, and breakage, and may lead to infection, medication loss, and/or blood loss.
Which Products Are Affected
The affected product is Medline Convenience kits containing recalled Swan-Ganz Catheters, specifically CENTRAL AND ARTERIAL LINE TOTE DYNJ8407. A total of 9,272 kits are involved under UDI-DI 10198459704543, Lot 26DBB599. Distribution was nationwide in the United States, including the states of AZ, CA, FL, IL, MO, NJ, OH, OK, TN, TX, and WI.
What You Should Do
Consumers should follow instructions provided by the recalling firm via email, fax, letter, press release, telephone, or visit.
Why This Matters
The Class II recall involves devices that may cause temporary or medically reversible adverse health consequences.
Source
FDA recall number Z-2608-2026, initiated May 28, 2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,122 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 7, 2026.
Frequently Asked Questions
Common questions about this FDA recall.